stars 1 stars 2 stars 3

Formerly known as T.D.M.S.2000, PrecisePK has been institutionally trusted for over 30 years for its clinical experience. Since 1986, we have served world-renowned institutions such as UC San Diego, Sharp Healthcare, UCSF Benioff Children’s Hospital, Scripps Health, and many more. PrecisePK is now an industry-leading therapeutic drug monitoring software for Bayesian model-informed precision dosing. It provides evidence-based individualized dosing recommendations for clinical pharmacists, accounting for even the most complex patient cases. PrecisePK is validated as the most accurate and the least biased Bayesian-guided software. (Turner et al 2018; 38(12):1174-1183 ACCP) PrecisePK utilizes patients’ specific conditions, physical characteristics, lab results, and dosage history to compute dosing recommendations. The software also generates predictive models, graphical visualizations based on patients’ serum blood levels, and therapeutics status analytics. When integrated with EHR, PrecisePK will retrieve patient information from EHR to reduce transcription errors, streamline clinical workflow, enable quick and accurate dosing analysis, and improve patient care.

PrecisePK Questions

The PrecisePK annual revenue was $189000 in 2026.

Anjum Gupta is the CEO of PrecisePK.

12 people are employed at PrecisePK.

PrecisePK is based in San Diego, California.

The NAICS codes for PrecisePK are [541, 541511, 54, 5415, 54151].

The SIC codes for PrecisePK are [737, 73].

Top PrecisePK Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users